Mustang Bio Competitors and Similar CompaniesClear all

Mustang Bio's competitors and similar companies include CRISPR Therapeutics, Intellia Therapeutics, AnGes and Lexicon Pharmaceuticals.

	Mustang Bio Mustang Bio is a clinical-stage biopharmaceutical company that specializes in the development of cell and gene therapies.	CRISPR Therapeutics CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Founding Date	Founding Date 2015	Founding Date 2013	Founding Date 2014	Founding Date 1999	Founding Date 1995
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Worcester, US HQ	Locations Zug, CH HQ Greater London, GB Cambridge, US San Francisco, US	Locations Cambridge, US HQ	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more
Employees	Employees 693% decrease	Employees 393	Employees 40323% decrease	Employees 5562% decrease	Employees 20216% increase
Valuation ($)	Valuation ($) 11.2 m	Valuation ($) 4.2 b	Valuation ($) 1.7 b	Valuation ($) 78.3 m	Valuation ($) 737.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $3.5m (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) $49.8m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)	Cost of goods $274k (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥374.2m (FY, 2025)	Gross profit $49.5m (FY, 2025)
Net income	Net income ($1.9m) (FY, 2025)	Net income ($581.6m) (FY, 2025)	Net income ($412.7m) (FY, 2025)	Net income (¥5.1b) (FY, 2025)	Net income ($50.3m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 127m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 244.7m